900.655477

[Ãëàâíàÿ/Ïîèñê] [Ïðîèçâîäèòåëè] [Ìîñêâà] [Ñ-Ïá] [Äðóãèå] [Îáùèé] [Çàÿâêè] [Âûáîðêà]

Öåíû íà ÍÀÁÎÐ ÈÇÄ. Ä/ÃÈÍÅÊÎË - ÍÓÐÎÔÅÍ ÔÎÐÒÅ ÒÀÁË. 400 ÌÃ Õ12

Ïðîäàâåö: ÏÓËÜÑ (Ñàíêò-Ïåòåðáóðã, (812) 108-21-58(-59), 108-20-18(-22), 103-44-38(-39))

ÍàèìåíîâàíèåÏðîèçâîäèòåëüÖåíà $Öåíà ðóá
ÍÀÁÎÐ ÈÇÄ. Ä/ÃÈÍÅÊÎË. ÎÑÌÎÒÐÀ ÎÄÍÎÐÀÇ. ÑÒÅÐÈËÜÍÛÉÔÀÐÌ ÁÑÊ29.32
ÍÀÁÎÐ ÈÇÄ. Ä/ÃÈÍÅÊÎË. ÎÑÌÎÒÐÀ ÎÄÍÎÐÀÇ. ÑÒÅÐÈËÜÍÛÉÔÀÐÌ ÁÑÊ29.6
ÍÀÁÎÐ ÈÇÄ. Ä/ÃÈÍÅÊÎË. ÎÑÌÎÒÐÀ ÎÄÍÎÐÀÇ. ÑÒÅÐÈËÜÍÛÉÔÀÐÌ ÁÑÊ29.61
ÍÀÁÎÐ ÈÇÄ. Ä/ÃÈÍÅÊÎË. ÎÑÌÎÒÐÀ ÎÄÍÎÐÀÇ. ÑÒÅÐÈËÜÍÛÉÔÀÐÌ ÁÑÊ29.61
ÍÀÇÈÂÈÍ ÊÀÏËÈ 0.01 % ÔË. 5 ÌË. Õ1E.MERCK74.34
ÍÀÇÈÂÈÍ ÊÀÏËÈ 0.025 % ÔË. 10 ÌË. Õ1E.MERCK72.62
ÍÀÇÈÂÈÍ ÑÏÐÅÉ 0.05 % ÔË. 10 ÌË. Õ1E.MERCK74.19
ÍÀÇÎË ÀÄÂÀÍÑ ÑÏÐÅÉ 0.05 % 30 ÌË. Õ1SAGMEL INC/INSTITUTO DE A124.35
ÍÀÇÎË ÁÅÁÈ ÊÀÏËÈ ÍÀÇ.Ä/ÄÅÒÅÉ 0.125 % ÔË. 15 ÌË. Õ1SAGMEL INC82.2
ÍÀÇÎË ÊÈÄÑ ÑÏÐÅÉ 0.25 % ÔË. 15 ÌË. Õ1SAGMEL INC77.83
ÍÀÇÎË ÑÏÐÅÉ 0.05 % 15 ÌË. Õ1SAGMEL INC/INSTITUTO DE A80.97
ÍÀÇÎË ÑÏÐÅÉ 0.05 % 30 ÌË. Õ1SAGMEL INC/INSTITUTO DE A108.48
ÍÀÉÇ ÃÅËÜ 1 % 20 Ã. Õ1DR.REDDY`S LABORATORIES L88.16
ÍÀÉÇ ÒÀÁË. 100 ÌÃ Õ20DR.REDDY`S LABORATORIES L76.6
ÍÀÉÇ ÒÀÁË. 50 ÌÃ Õ20DR.REDDY`S LABORATORIES L35.87
ÍÀÏÀËÜ×ÍÈÊÈ ËÀÒÅÊÑ.  ÈÍÄ. ÓÏÀÊ. Õ5ÀÌÒ - ÒÐÅÉÄ2.94
ÍÀÏÀËÜ×ÍÈÊÈ ËÀÒÅÊÑ. Õ100ÀÌÒ - ÒÐÅÉÄ39.28
ÍÀÒÐÈß ÃÈÄÐÎÊÀÐÁÎÍÀÒ-ÝÑÊÎÌ Ð-Ð 5 % 200 ÌË. Õ1ÝÑÊÎÌ98.87
ÍÀÒÐÈß ÒÅÒÐÀÁÎÐÀÒ Ð-Ð Â ÃËÈÖÅÐ. 20 % ÔË. 30 Ã. Õ1ÒÂÅÐÑÊÀß ÔÀÐÌ. ÔÀÁÐÈÊÀ6.82
ÍÀÒÐÈß ÒÈÎÑÓËÜÔÀÒ Ð-Ð 30 % ÀÌÏ. 10 ÌË. Õ10ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ45
ÍÀÒÐÈß ÔÒÎÐÈÄ ÒÀÁË. Ä/ÄÅÒÅÉ 1.1 ÌÃ Õ50ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ6.18
ÍÀÒÐÈß ÕËÎÐÈÄ Ð-Ð 0.9 % ÀÌÏ. 10 ÌË. Õ10ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ27.11
ÍÀÒÐÈß ÕËÎÐÈÄ Ð-Ð 0.9 % ÀÌÏ. 10 ÌË. Õ10ÍÎÂÎÑÈÁÕÈÌÔÀÐÌ27.11
ÍÀÒÐÈß ÕËÎÐÈÄ Ð-Ð 0.9 % ÀÌÏ. 5 ÌË. Õ10ÁÎÐÈÑÎÂÑÊÈÉ ÇÀÂÎÄ16.44
ÍÀÒÐÈß ÕËÎÐÈÄ Ð-Ð 0.9 % ÀÌÏ. 5 ÌË. Õ10ÌÈÊÐÎÃÅÍ - ÍÏÎ ÂÈÐÈÎÍ16.23
ÍÀÒÐÈß ÕËÎÐÈÄ Ð-Ð 0.9 % ÔË. 100 ÌË. (ÊÏ-1) Õ1ÌÅÄÏÎËÈÌÅÐ22.63
ÍÀÒÐÈß ÕËÎÐÈÄ Ð-Ð 0.9 % ÔË. 100 ÌË. Õ1ÝÑÊÎÌ17.41
ÍÀÒÐÈß ÕËÎÐÈÄ Ð-Ð 0.9 % ÔË. 200 ÌË. Õ1ÝÑÊÎÌ21.52
ÍÀÒÐÈß ÕËÎÐÈÄ Ð-Ð 0.9 % ÔË. 250 ÌË. (ÊÏ-1 ÏÏ) Õ1ÌÅÄÏÎËÈÌÅÐ27.45
ÍÀÒÐÈß ÕËÎÐÈÄ Ð-Ð 0.9 % ÔË. 250 ÌË. (ÊÏ-1) Õ1ÌÅÄÏÎËÈÌÅÐ27.45
ÍÀÒÐÈß ÕËÎÐÈÄ Ð-Ð 0.9 % ÔË. 400 ÌË. Õ1ÌÈÊÐÎÃÅÍ - ÈÌÌÓÍÎÏÐÅÏÀÐÀÒ26.01
ÍÀÒÐÈß ÕËÎÐÈÄ Ð-Ð 0.9 % ÔË. 500 ÌË. (ÊÏ-1) Õ1ÌÅÄÏÎËÈÌÅÐ29.94
ÍÀÔÒÀÄÅÐÌ (ËÈÍ. ÍÀÔÒ. ÍÅÔÒÈ) 10 % 35 Ã. Õ1ÐÅÒÈÍÎÈÄÛ349.61
ÍÀÔÒÈÇÈÍ ÊÀÏËÈ 0.05 % ÔË. 10 ÌË. Õ1ÑËÀÂßÍÑÊÀß ÀÏÒÅÊÀ2.71
ÍÀÔÒÈÇÈÍ ÊÀÏËÈ 0.05 % ÔË./ÊÀÏ. ÏËÀÑÒ. 10 ÌË. Õ1ÑËÀÂßÍÑÊÀß ÀÏÒÅÊÀ3.42
ÍÀÔÒÈÇÈÍ ÊÀÏËÈ 0.05 % ÔË./ÊÀÏ. ÏËÀÑÒ. 15 ÌË. Õ1ÑËÀÂßÍÑÊÀß ÀÏÒÅÊÀ4.33
ÍÀÔÒÈÇÈÍ ÊÀÏËÈ 0.1 % ÔË. 10 ÌË. Õ1ÑËÀÂßÍÑÊÀß ÀÏÒÅÊÀ2.59
ÍÀÔÒÈÇÈÍ ÊÀÏËÈ 0.1 % ÔË./ÊÀÏ. ÏËÀÑÒ. 10 ÌË. Õ1ÑËÀÂßÍÑÊÀß ÀÏÒÅÊÀ3.92
ÍÀÔÒÈÇÈÍ ÊÀÏËÈ 0.1 % ÔË./ÊÀÏ. ÏËÀÑÒ. 15 ÌË. Õ1ÑËÀÂßÍÑÊÀß ÀÏÒÅÊÀ4.04
ÍÀØÀÒÛÐÍÎ-ÀÍÈÑÎÂÛÅ ÊÀÏËÈ ÔË. 25 ÌË. Õ1ÒÂÅÐÑÊÀß ÔÀÐÌ. ÔÀÁÐÈÊÀ6.61
ÍÀßÒÎÊÑ ÌÀÇÜ ÒÓÁÀ 20 Ã. Õ1ÌÅÊÎÔÀÐ73.67
ÍÅÁÈËÅÒ ÒÀÁË. 5 ÌÃ Õ14BERLIN-CHEMIE AG/MENARINI415.3
ÍÅÁÈËÅÒ ÒÀÁË. 5 ÌÃ Õ28BERLIN-CHEMIE AG/MENARINI785.36
ÍÅÂÈÃÐÀÌÎÍ ÊÀÏÑ. 500 ÌÃ Õ56CHINOIN789.7
ÍÅÃÐÓÑÒÈÍ ÊÀÏÑ. 425 ÌÃ Õ30HEXAL AG/SALUTAS PHARMA153.77
ÍÅÃÐÓÑÒÈÍ Ð-Ð ÔË. 50 ÌË. Õ1SALUTAS PHARMA GMBH158.11
ÍÅÉÐÎÌÓËÜÒÈÂÈÒ ÒÀÁË. Ï/Î Õ20LANNACHER HEILMITTEL GMBH148.33
ÍÅÎÑÌÅÊÒÈÍ ÏÎÐ. 3 Ã. Õ10ÔÀÐÌÏÐÎÅÊÒ86.57
ÍÅÎÑÌÅÊÒÈÍ ÏÎÐ. 3 Ã. Õ30ÔÀÐÌÏÐÎÅÊÒ220.63
ÍÅÎÑÌÅÊÒÈÍ ÏÎÐ. 3 Ã. Õ3ÔÀÐÌÏÐÎÅÊÒ28.41
ÍÈÇÎÐÀË ØÀÌÏÓÍÜ ÔË. 25 ÌË. Õ1JANSSEN PHARMACEUTICA N.V237.63
ÍÈÊÎÐÅÒÒÅ Ð-Ð Ä/ÈÍÃÀË. 10 ÌÃ (Â ÊÎÌË. Ñ ÌÓÍÄØÒÓÊÎÌPFIZER HEALTH AB270.31
ÍÈÊÎÐÅÒÒÅ Ð-Ð Ä/ÈÍÃÀË. 10 ÌÃ (Â ÊÎÌÏË. Ñ ÌÓÍÄØÒÓÊÎPFIZER HEALTH AB165.75
ÍÈÊÎÐÅÒÒÅ ÐÅÇÈÍÊÀ ÆÅÂÀÒ. 2 ÌÃ (ÌßÒÍÛÅ) Õ30PFIZER HEALTH AB249.11
ÍÈÊÎÐÅÒÒÅ ÐÅÇÈÍÊÀ ÆÅÂÀÒ. 2 ÌÃ Õ30MCNEIL AB243.29
ÍÈÊÎÐÅÒÒÅ ÐÅÇÈÍÊÀ ÆÅÂÀÒ. 4 ÌÃ (ÌßÒÍÛÅ) Õ30PFIZER HEALTH AB239.72
ÍÈÊÎÐÅÒÒÅ ÒÒÑ ÑÀØÅ (10ÌÃ/16×) Õ7MCNEIL AB624.59
ÍÈÊÎÐÅÒÒÅ ÒÒÑ ÑÀØÅ (15ÌÃ/16×) Õ7MCNEIL AB587.69
ÍÈÊÎÐÅÒÒÅ ÒÒÑ ÑÀØÅ (5ÌÃ/16×) Õ7MCNEIL AB622.12
ÍÈÊÎÒÈÍÎÂÀß ÊÈÑËÎÒÀ Ð-Ð 1 % ÀÌÏ. 1 ÌË. Õ10ÇÄÎÐÎÂÜÅ ÇÀÎ ÔÀÐÌÀÖÅÂÒÈ×Å10.93
ÍÈÊÎÒÈÍÎÂÀß ÊÈÑËÎÒÀ Ð-Ð 1 % ÀÌÏ. 1 ÌË. Õ10ÎÐÃÀÍÈÊÀ13.19
ÍÈÊÎÒÈÍÎÂÀß ÊÈÑËÎÒÀ ÒÀÁË. 50 ÌÃ Õ50ÈÐÁÈÒÑÊÈÉ ÕÈÌÈÊÎ-ÔÀÐÌÀÖÅÂ7.56
ÍÈÊÎÔËÅÊÑ ÌÀÇÜ 50 Ã. Õ1REANAL152.78
ÍÈÌÅÑÈË ÃÐÀÍ. Ä/ÏÐÈÃÎÒ.ÑÓÑÏ. 100 ÌÃ 2 Ã. Õ30LABORATORI GUIDOTTI S.P.A488.5
ÍÈÌÅÑÓËÈÄ ÒÀÁË. 100 ÌÃ Õ20ÐÅÏËÅÊÔÀÐÌ/ÁÅÐÅÇÎÂÑÊÈÉ ÇÀ55.05
ÍÈÑÒÀÒÈÍ ÌÀÇÜ 100000 ÅÄ 30 Ã. Õ1ÁÈÎÑÈÍÒÅÇ25.25
ÍÈÑÒÀÒÈÍ ÒÀÁË. 250000 ÅÄ Õ20ÁÈÎÑÈÍÒÅÇ13.26
ÍÈÑÒÀÒÈÍ ÒÀÁË. 500000 ÅÄ Õ20ÁÈÎÑÈÍÒÅÇ20.89
ÍÈÒÐÎÃËÈÖÅÐÈÍ ÊÀÏÑ. 0.5 ÌÃ Õ20ËÞÌÈ4.62
ÍÈÒÐÎÃËÈÖÅÐÈÍ ÒÀÁË. 0.5 ÌÃ Õ40ÎÇÎÍ23.93
ÍÈÒÐÎÊÎÐ ÒÀÁË. 0.5 ÌÃ Õ40ÔÀÐÌÑÒÀÍÄÀÐÒ ËÅÊÑÐÅÄÑÒÂÀ29.63
ÍÈÒÐÎÊÑÎËÈÍ ÒÀÁË. 50 ÌÃ Õ50ÈÐÁÈÒÑÊÈÉ ÕÈÌÈÊÎ-ÔÀÐÌÀÖÅÂ26.25
ÍÈÒÐÎÌÈÍÒ ÀÝÐÎÇ. 1 % 10 Ã. Õ1EGIS138.02
ÍÈÒÐÎÍÃ ÔÎÐÒÅ ÏÐÎËÎÍÃ. ÄÅÉÑÒÂ. ÒÀÁË. 6.5 ÌÃ Õ25KRKA89.65
ÍÈÒÐÎÑÎÐÁÈÄ ÒÀÁË. 10 ÌÃ Õ25ÔÀÐÌÑÒÀÍÄÀÐÒ ÒÎÌÑÊ5.55
ÍÈÒÐÎÑÎÐÁÈÄ ÒÀÁË. 10 ÌÃ Õ50ÔÀÐÌÀÏÎË-ÂÎËÃÀ5.57
ÍÈÒÐÎÑÏÐÅÉ ÑÏÐÅÉ 1 % 10 ÌË. Õ1ÔÀÐÌÑÒÀÍÄÀÐÒ ËÅÊÑÐÅÄÑÒÂÀ73.6
ÍÈÒÐÎÔÓÍÃÈÍ Ð-Ð Ä/ÍÀÐÓÆ.ÏÐÈÌ. ÔË. 25 ÌË. Õ1IVAX - CR38.62
ÍÈÔÅÄÈÏÈÍ ÄÐÀÆÅ 10 ÌÃ Õ50BALKANPHARMA26.76
ÍÈÖÅÐÃÎËÈÍ Ð-Ð 4 ÌÃ ÀÌÏ. 5 ÌË. Õ5ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ459.73
ÍÎ-ØÏÀ Ð-Ð Â/Â È Â/Ì ÂÂÅÄ. 40 ÌÃ ÀÌÏ. 2 ÌË. Õ25CHINOIN392.02
ÍÎ-ØÏÀ ÒÀÁË. 40 ÌÃ ÔË./ÄÎÇÀÒÎÐ Õ60CHINOIN149.62
ÍÎ-ØÏÀ ÒÀÁË. 40 ÌÃ Õ100CHINOIN176.94
ÍÎ-ØÏÀ ÒÀÁË. 40 ÌÃ Õ20CHINOIN65.61
ÍÎ-ØÏÀËÃÈÍ ÒÀÁË. Õ12CHINOIN101.87
ÍÎÂÈÃÀÍ 400 ÌÃ Õ20DR.REDDY`S LABORATORIES L32.11
ÍÎÂÎ-ÏÀÑÑÈÒ Ð-Ð ÔË. 100 ÌË. Õ1IVAX - CR88.61
ÍÎÂÎ-ÏÀÑÑÈÒ Ð-Ð ÔË. 200 ÌË. Õ1IVAX - CR170.1
ÍÎÂÎ-ÏÀÑÑÈÒ ÒÀÁË. Ï/Î 200 ÌÃ Õ30IVAX - CR280.37
ÍÎÂÎ-ÏÀÑÑÈÒ ÒÀÁË. Ï/Î 200 ÌÃ Õ60IVAX - CR404.82
ÍÎÂÎÊÀÈÍ Ð-Ð 0.5 % ÀÌÏ. 10 ÌË. Õ10ÄÀËÜÕÈÌÔÀÐÌ23.5
ÍÎÂÎÊÀÈÍ Ð-Ð 0.5 % ÀÌÏ. 5 ÌË. Õ10ÎÐÃÀÍÈÊÀ15.61
ÍÎÂÎÊÀÈÍ Ð-Ð 0.5 % ÔË. 400 ÌË. Õ1ÁÈÎÑÈÍÒÅÇ23.47
ÍÎÂÎÊÀÈÍ Ð-Ð 2 % ÀÌÏ. 2 ÌË. Õ10ÁÎÐÈÑÎÂÑÊÈÉ ÇÀÂÎÄ8.86
ÍÎÃÎÒÊÈ ÖÂÅÒÊÈ Ô/Ï. 1.5 Ã. Õ20ÊÐÀÑÍÎÃÎÐÑÊ ËÅÊ ÑÐ-ÂÀ31.32
ÍÎËÈÏÐÅË ÒÀÁË. 2 ÌÃ (+0,625 ÌÃ) Õ30SERVIER365.49
ÍÎËÈÏÐÅË ÔÎÐÒÅ ÒÀÁË. 4 ÌÃ (+1,25 ÌÃ) Õ30SERVIER567.76
ÍÎËÈÖÈÍ ÒÀÁË. Ï/Î 400 ÌÃ Õ10KRKA ? ÐÓÑ107.47
ÍÎËÈÖÈÍ ÒÀÁË. Ï/Î 400 ÌÃ Õ20KRKA ? ÐÓÑ202.65
ÍÎÎÒÐÎÏÈË ÊÀÏÑ. 400 ÌÃ Õ60UCB S.A. PHARMA SECTOR204.64
ÍÎÎÒÐÎÏÈË Ð-Ð ÀÌÏ. 15 ÌË. Õ4UCB S.A. PHARMA SECTOR349.98
ÍÎÎÒÐÎÏÈË Ð-Ð Â/Â È Â/Ì ÂÂÅÄ. 20 % ÀÌÏ. 5 ÌË. Õ12UCB S.A. PHARMA SECTOR434.35
ÍÎÎÒÐÎÏÈË ÒÀÁË. Ï/Î 800 ÌÃ Õ30UCB S.A. PHARMA SECTOR279.96
ÍÎÐÁÀÊÒÈÍ 400 ÌÃ Õ10RANBAXY65.21
ÍÎÐÂÀÑÊ ÒÀÁË. 10 ÌÃ Õ14HEINRICH MACK372.86
ÍÎÐÂÀÑÊ ÒÀÁË. 10 ÌÃ Õ30HEINRICH MACK766.83
ÍÎÐÂÀÑÊ ÒÀÁË. 5 ÌÃ Õ14HEINRICH MACK206.93
ÍÎÐÂÀÑÊ ÒÀÁË. 5 ÌÃ Õ30HEINRICH MACK410.14
ÍÎÐÌÎÄÈÏÈÍ ÒÀÁË. 10 ÌÃ Õ30GEDEON RICHTER686.81
ÍÎÐÌÎÄÈÏÈÍ ÒÀÁË. 5 ÌÃ Õ30GEDEON RICHTER375.92
ÍÓÐÎÔÅÍ /ÊËÓÁÍÈÊÀ/ ÑÓÑÏ. Ä/ÄÅÒÅÉ 100 Õ1RECKITT BENCKISER S.A./ÁÑ101.93
ÍÓÐÎÔÅÍ /Ñ ÀÏÅËÜÑÈÍ.ÂÊÓÑÎÌ/ ÑÓÑÏ. Ä/ÄÅÒÅÉ 100 Õ1RECKITT BENCKISER S.A./ÁÑ95.78
ÍÓÐÎÔÅÍ ÃÅËÜ 5 % ÒÓÁÀ 50 Ã. Õ1FARMASIERRA MANUFACTURING123.53
ÍÓÐÎÔÅÍ ÏËÞÑ ÒÀÁË. Ï/Î 200 ÌÃ Õ12RECKITT BENCKISER S.A.107.96
ÍÓÐÎÔÅÍ ÑÂÅ×È ÐÅÊÒ. ÄÅÒÑÊÈÅ 60 Ìà Õ10RECKITT BENCKISER HEALTHC101.94
ÍÓÐÎÔÅÍ ÒÀÁË. Ï/Î 200 ÌÃ Õ12RECKITT BENCKISER/BOOTS H53.13
ÍÓÐÎÔÅÍ ÒÀÁË. Ï/Î 200 ÌÃ Õ24RECKITT BENCKISER/BOOTS H97.55
ÍÓÐÎÔÅÍ ÒÀÁË. Ï/Î 200 ÌÃ Õ6RECKITT BENCKISER/BOOTS H34.52
ÍÓÐÎÔÅÍ ÓËÜÒÐÀÊÀÏ ÊÀÏÑ. 200 ÌÃ Õ10BOOTS HEALTHCARE/BANNER P78.62
ÍÓÐÎÔÅÍ ÓËÜÒÐÀÊÀÏ ÊÀÏÑ. 200 ÌÃ Õ4RECKITT BENCKISER HEALTHC43.49
ÍÓÐÎÔÅÍ ÔÎÐÒÅ ÒÀÁË. 400 ÌÃ Õ12RECKITT BENCKISER/BOOTS H82.74





2001-2011 http://www.med.sgg.ru - öåíû íà ëåêàðñòâà, ìåäòåõíèêó, âñå äëÿ ñòîìàòîëîãèè, õèðóðãè÷åñêèé è äðóãîé ìåäèöèíñêèé èíñòðóìåíò è òåõíèêà, ôàðìàöåâòè÷åñêèå ïðåïàðàòû è ñóáñòàíöèè îò ïðîèçâîäèòåëåé è îïòîâûõ ïðîäàâöîâ â Ìîñêâå, Ñàíêò-Ïåòåðáóðãå è äðóãèõ ðåãèîíàõ.



Rambler's Top100 Rambler's Top100 Ðåéòèíã@Mail.ru